AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03849209 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stylet slow-pull technique
Description: During endosonographic examination, the pancreatic mass was evaluated with color Doppler to avoid the involvement of vessels. The needle (20 Gauge, EchoTip ProCore 20G with ReCoil Stylet™, Cook Medical, Bloomington, IN, USA) was sharpened by withdrawing the stylet approximately 2 mm, and then was advanced into the lesion: 15 to-and-fro movements within the lesion were performed, with simultaneous minimal negative pressure provided by pulling the needle stylet slowly and continuously.
Study NCT03849209 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard suction technique
Description: During endosonographic examination, the pancreatic mass was evaluated with color Doppler to avoid the involvement of vessels. The needle (20 Gauge, EchoTip ProCore 20G with ReCoil Stylet™, Cook Medical, Bloomington, IN, USA) was sharpened by withdrawing the stylet approximately 2 mm, and then was advanced into the lesion: 15 to-and-fro movements within the lesion were performed using a 10-mL suction syringe.
Study NCT02398214 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep hygiene
Description: LAST intervention (light, activity, and sleep training) consists of behavioral and educational strategies for increasing light exposure and physical activity, minimizing television viewing and reducing television viewing time to \< 2 hours per day, and engaging activities suitable to the child's motor development to minimize sleep disturbance.
Study NCT03621696 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity modulated proton therapy
Description: -IMRT or IMPT can be used
Study NCT03621696 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: -Standard of care
Study NCT03621696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FACT-H&N
Description: -Baseline, interim assessment (14-42 days post-surgery), day 1 of radiation, day 21 of radiation, day 36 of radiation, 6 weeks after completion of adjuvant therapy, 4 months after the completion of adjuvant therapy, 6 months after the completion of adjuvant therapy, 12 months after the completion of adjuvant therapy, and 24 months after completion of adjuvant therapy
Study NCT03621696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MD Anderson Dysphagia Inventory
Description: -Baseline, interim assessment (14-42 days post-surgery), day 1 of radiation, day 21 of radiation, day 36 of radiation, 6 weeks after completion of adjuvant therapy, 4 months after the completion of adjuvant therapy, 6 months after the completion of adjuvant therapy, 12 months after the completion of adjuvant therapy, and 24 months after completion of adjuvant therapy
Study NCT03621696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: University of Michigan Xerostomia Index
Description: -Baseline, interim assessment (14-42 days post-surgery), day 1 of radiation, day 21 of radiation, day 36 of radiation, 6 weeks after completion of adjuvant therapy, 4 months after the completion of adjuvant therapy, 6 months after the completion of adjuvant therapy, 12 months after the completion of adjuvant therapy, and 24 months after completion of adjuvant therapy
Study NCT03621696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scale of Subjective Total Taste Acuity
Description: -Baseline, interim assessment (14-42 days post-surgery), day 1 of radiation, day 21 of radiation, day 36 of radiation, 6 weeks after completion of adjuvant therapy, 4 months after the completion of adjuvant therapy, 6 months after the completion of adjuvant therapy, 12 months after the completion of adjuvant therapy, and 24 months after completion of adjuvant therapy
Study NCT03621696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neck Dissection Impairment Index
Description: -Baseline, interim assessment (14-42 days post-surgery), day 1 of radiation, day 21 of radiation, day 36 of radiation, 6 weeks after completion of adjuvant therapy, 4 months after the completion of adjuvant therapy, 6 months after the completion of adjuvant therapy, 12 months after the completion of adjuvant therapy, and 24 months after completion of adjuvant therapy
Study NCT03127995 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: HYPOFRACTIONATED
Description: 40 Gy/ 15 fractions / 3 weeks
Study NCT03127995 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: NORMOFRACTIONATED
Description: 50 Gy/ 25 fractions / 5 weeks
Study NCT03264235 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Keeogo
Description: Keeogo is a computer-controlled lower extremity motorized orthosis worn over the user's hips and legs. The controller box contains sensors that supply information about the kinematics and the kinetics of the user's lower extremities and includes software that recognizes the user's mobility intentions. The system is powered by a lithium-polymer battery. The leg brace assembly is mainly comprised of the actuator, the electronic boards, hip joint, and soft goods (cuffs, belts) for affixing the assembly to the user's legs. The waist belt comes in various sizes adapted to each wearer, and adds additional support of the device on the user.~Keeogo does not initiate any movement but waits for the user's lead. Once the user makes the first move, Keeogo assists according to the activity. The individual must be able to initiate and terminate steps.
Study NCT03264235 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Stair Training
Description: Individuals will participate in traditional stair training physical therapy for the same duration of time as Group 1.
Study NCT02352610 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: LRTI
Study NCT02352610 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Biotenodesis Screw
Study NCT00208312 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regadenoson
Description: 0.4 mg, bolus intravenous injection
Study NCT00208312 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adenosine
Description: 0.14 mg/kg/min for 6 minutes, intravenous infusion
Study NCT02498561 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: nonsurgical periodontal therapy
Description: Scaling and root planning under local anaesthesia, in a total of four clinical visits Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush.
Study NCT02498561 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: oral hygiene instructions
Description: Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush
Study NCT01947244 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Doula Home Visiting
Description: The intervention is a doula enhancement to evidence-based home visiting services. Doulas provide home visits during pregnancy and for the first six weeks postpartum, which focus on prenatal health, preparation for childbirth, bonding with the baby, and breastfeeding education. Family support workers provide longer term home visiting services. These home visits focus on sensitive and responsive parenting, early infant care, bonding with the baby, child health and development, and maternal mental health.
Study NCT01947244 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Case management
Description: Mothers are offered two prenatal and two postpartum case management meetings to assess whether mothers' basic needs (housing, nutrition, health care, mental health) are being met and make appropriate referrals.
Study NCT01688167 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MC and sexual risk reduction
Description: Four group counselling sessions focused on male circumcision and sexual risk reduction
Study NCT02755844 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Olaparib tablet dose will be dose-escalated on 4 dose levels , guided by a continual reassessment method (CRM).~One cycle will be 28 days (4 weeks) in duration, except for cycle 1 which will be 6 weeks.
Study NCT02755844 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: metformin
Description: From week 3 metformin will be gradually escalated from 500 mg/day to 1500 mg/day with weekly 500 mg dose escalation levels
Study NCT03818178 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Intralipid
Description: Half of the participants will receive either naso-duodenal infusion of intralipid or palm oil each participant will serve as their own saline control on the second study day.
Study NCT03818178 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Palm Oil Emulsion
Description: Half of the participants will receive either naso-duodenal infusion of intralipid or palm oil each participant will serve as their own saline control on the second study day.
Study NCT03818178 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: All participants will serve as their own controls with a saline infusion study day.
Study NCT04213209 — intervention group
Intervention type: DRUG
Intervention: Brentuximab Vedotin (Genetical Recombination)
Description: Brentuximab Vedotin Intravenous Infusion
Study NCT02755844 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: metronomic cyclophosphamide
Description: from week 2 Metronomic cyclophosphamide will be given continuously on an oral daily basis at 50 mg qd
Study NCT01331863 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Airway and/or pulmonary Vessels Transplantation
Description: Use of a stent-supported aortic allograft to prevent pneumonectomy in lung cancer SURGERY
Study NCT02906111 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: estriol
Description: Study Group, treated with estriol~Control Group, no drug treatment~Both groups will undergo vaginal surgery for prolapse
Study NCT02906111 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: vaginal surgery
Description: Control Group
Study NCT02052843 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Steps to Success
Study NCT02052843 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Healthy Families
Study NCT03769935 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cis Platinum, etoposide, S1
Description: cisplatin 75 mg/m2, iv day1, Etoposide: 60 mg/m2 IV day 1-5, every 21 days for up to 4-6 cycles.~S1 25 mg/m2 oral, everyday until progression disease
Study NCT03769935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cis Platinum, etoposide, S1
Description: cisplatin 75 mg/m2, iv day1, Etoposide: 60 mg/m2 IV day 1-5, every 21 days for up to 4-6 cycles.~S1 25 mg/m2 oral, everyday until progression disease
Study NCT00743600 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ultrasound of painful shoulder
Description: Patients who have a shoulder that is painful or has limited movement who were referred to Radiology will have an ultrasound exam of their shoulder.
Study NCT00743600 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound
Description: Healthy volunteers who do not have pain or limited movement will have an ultrasound exam of their shoulder.
Study NCT02140359 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Network Interview
Description: Residents of a housing first permanent supporting housing program will be randomly assigned to this arm after screening and baseline assessments. They will meet roughly every two weeks with a case manager and answer questions about their social network, will be shown visual feedback about their networks, and will participate in a motivational interview conducted by the case managers. The questions and visualizations will be facilitated by an electronic tool for presenting screens with questions, capturing responses, processing and visualizing social network data.
Study NCT01096849 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: levofloxacin
Study NCT01096849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: plazomicin
Study NCT04136470 — intervention group
Intervention type: BIOLOGICAL
Intervention: Collection of stool, blood (PBMC) and biopsy (FFPE)
Description: Patients receiving routine treatment (immunotherapy using anti-PD1 / anti-PDL1 and / or anti CTLA4 antibodies), financed by the Polish National Health Fund (NFZ).
Study NCT01096849 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Study NCT01096849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Study NCT03152448 — intervention group
Intervention type: BEHAVIORAL
Intervention: Prolaris
Description: Series of three questionnaires to capture treatment decisions based upon standard clinical-pathological information with the addition of Prolaris genomic testing result
Study NCT01073969 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: wheat bran extract
Description: Comparison of control cereal (containing no added wheat bran extract)to two test cereals containing different amounts of added wheat bran extract
Study NCT04005898 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Near-infrared fluorescence cholangiography
Description: Real-Time Fluorescence Imaging (VISERA ELITE II Imaging System). These device is used to identify anatomy, using infrared light that causes the indocianine green to fluoresce.
Study NCT01901731 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transjugular coil embolisation of pelvic veins
Study NCT01901731 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: endovenous treatment of leg varicose veins
Study NCT01901731 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: endovenous treatment of leg varicose veins
Study NCT01073969 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control wheat bran extract
Description: Comparison of control cereal (containing no added wheat bran extract) to two test cereals containing different amounts of added wheat bran extract
Study NCT03182400 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurophysiological assessment
Description: Assessment of cerebral electrical activity Assessment of ocular exploration Neurovegetative assessments
Study NCT03182400 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neuropsychological assessment
Description: sub-tests, scales, surveys, reaction time measurement
Study NCT02551198 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HAPREP®
Description: Arm1: HAPREP® (2L polyethylene glycol with ascorbic acid; PEG-Asc)~: : PEG-Asc(500mLx2 times q30min)\[PM 7-9, the day before colonoscopy\] + PEG-Asc(500mLx2 times q30min)\[AM 5-7, the day of colonoscopy\]
Study NCT02551198 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SUCLEAR®
Description: Arm2: SUCLEAR® (oral sulfate solution; OSS): OSS(1b/177mL)\[PM 7-9, the day before colonoscopy\] + OSS(1b/177mL)\[AM 5-7, the day of colonoscopy\]
Study NCT01658696 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ChAd63 ME-TRAP and MVA ME-TRAP
Description: ChAd63 ME-TRAP: 5 x 10\^10vp MVA ME-TRAP: 2 x 10\^8 pfu heterologous prime-boost immunisation
Study NCT01658696 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Rabies vaccine
Description: 2 x 2.5IU Verorab
Study NCT01688089 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ODM103
Study NCT01688089 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT01688089 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entacapone
Study NCT01688089 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levodopa/carbidopa
Study NCT00951951 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Anterior Approach
Description: Anterior Minimal Invasive Surgery (AMIS)
Study NCT01845532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPI
Description: Trigger point injection with 25G needle on the shoulder before surgery(0.5% procaine, 0.25\~0.5% lidocaine, 0.125% bupivacaine)
Study NCT03169023 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ScaleDown
Description: -Participants receives behavioral prompts and daily feedback by text messaging with motivational instructions for specific dietary and behavior modifications
Study NCT03169023 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Usual Care Packets
Description: -From the American Cancer Society Website
Study NCT00951951 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Posterior Approach
Study NCT03418987 — intervention group
Intervention type: OTHER
Intervention: Medical File data analysis
Description: Analysis of the 2D/3D spine images (performed with the sterEOS software and the MATLAB software)
Study NCT01823276 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tyrosine-Containing Bar
Study NCT03169023 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care Packets
Description: -From the American Cancer Society Website
Study NCT03169023 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 12-Item Short Form Health Survey
Description: -Measures functional health and well-being from the patient's perspective
Study NCT03169023 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 12-Item Short Form Health Survey
Description: -Measures functional health and well-being from the patient's perspective
Study NCT03169023 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: International Physical Activity Questionnaire short form
Description: -7 item scale that measures a range of physical activity from vigorous to sedentary over the last 7 days
Study NCT03169023 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: International Physical Activity Questionnaire short form
Description: -7 item scale that measures a range of physical activity from vigorous to sedentary over the last 7 days
Study NCT01995097 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scheduled Gradual Reduction Text Messages
Study NCT01995097 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Support Text Messages
Study NCT01995097 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Support Text Messages
Study NCT02264314 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Communication Education Program
Description: A behavioral intervention aimed to improve the adherence to the hearing aid in older adults with hearing loss
Study NCT03169023 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multidimensional Body Self Relations Questionnaire - Appearance Subscales
Description: -Gold-standard for the assessment of body image attitudes and contains 34 items
Study NCT03169023 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Multidimensional Body Self Relations Questionnaire - Appearance Subscales
Description: -Gold-standard for the assessment of body image attitudes and contains 34 items
Study NCT01823276 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Bar
Study NCT02470091 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Denosumab
Description: Given SC
Study NCT01845532 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: EMLA cream
Description: EMLA cream with occluding dressing on the shoulder before surgery(5% of eutectic mixture with 2.5% lidocaine and 2.5% prilocaine)
Study NCT02470091 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02470091 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study NCT00597116 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vinorelbine
Study NCT00597116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vandetanib
Description: once daily oral dose
Study NCT00543452 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen
Description: 4 liters of oxygen a minute
Study NCT00543452 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Air from a placebo oxygen delivery
Description: 4 liters a minute of air from a placebo device
Study NCT01753414 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Description: Daily fractions
Study NCT01753414 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgery
Description: Radical resection
Study NCT00478049 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gefitinib
Description: 250 mg oral tablet
Study NCT00478049 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel
Description: intravenous infusion
Study NCT03122587 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Alternating Current Stimulation at 10 Hz
Description: Non-invasive, safe transcranial alternating current stimulation administered at 10 Hz to target alpha oscillatory activity
Study NCT02264314 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Participants in this arm will not receive intervention during the study protocol time. After the completion of the protocol, they will receive the same intervention that the intervention group, meaning the ACE program intervention.